Viewing Study NCT06481202


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-02-21 @ 11:18 PM
Study NCT ID: NCT06481202
Status: COMPLETED
Last Update Posted: 2024-07-01
First Post: 2024-06-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Pharmacokinetic Study of Complarate (Tocilizumab Biosimilar) and Actemra® in Healthy Volunteers
Sponsor: AO GENERIUM
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
Keywords:

Keywords

Keyword Brief Keyword Text View
None tocilizumab View
None humanized monoclonal antibodies View
None safety View
None pharmacokinetics View
None equivalence View
None biosimilar View
None IL-6 receptor View